BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 36556972)

  • 1. The Effect of Low Doses of Acetylsalicylic Acid on the Occurrence of Rectal Aberrant Crypt Foci.
    Kowalczyk M; Sigorski D; Dyśko Ł; Zieliński E; Zupanovich Lucka D; Klepacki Ł
    Medicina (Kaunas); 2022 Nov; 58(12):. PubMed ID: 36556972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The efficacy of aspirin and metformin combination therapy in patients with rectal aberrant crypt foci: a double-blinded randomized controlled trial.
    Higurashi T; Arimoto J; Ashikari K; Takatsu T; Misawa N; Yoshihara T; Matsuura T; Fuyuki A; Ohkubo H; Nakajima A
    BMC Cancer; 2020 Oct; 20(1):1043. PubMed ID: 33121471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of Difluoromethylornithine and Aspirin for Treatment of Adenomas and Aberrant Crypt Foci in Patients with Prior Advanced Colorectal Neoplasms.
    Sinicrope FA; Velamala PR; Song LMWK; Viggiano TR; Bruining DH; Rajan E; Gostout CJ; Kraichely RE; Buttar NS; Schroeder KW; Kisiel JB; Larson MV; Sweetser SR; Sedlack RR; Sinicrope SN; Richmond E; Umar A; Della'Zanna G; Noaeill JS; Meyers JP; Foster NR
    Cancer Prev Res (Phila); 2019 Nov; 12(11):821-830. PubMed ID: 31484660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rectal aberrant crypt foci (ACF) as a predictor of benign and malignant neoplastic lesions in the large intestine.
    Kowalczyk M; Orłowski M; Klepacki Ł; Zinkiewicz K; Kurpiewski W; Kaczerska D; Pesta W; Zieliński E; Siermontowski P
    BMC Cancer; 2020 Feb; 20(1):133. PubMed ID: 32075595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation of the prevalence and number of aberrant crypt foci associated with human colorectal neoplasm.
    Sakai E; Takahashi H; Kato S; Uchiyama T; Hosono K; Endo H; Maeda S; Yoneda M; Taguri M; Nakajima A
    Cancer Epidemiol Biomarkers Prev; 2011 Sep; 20(9):1918-24. PubMed ID: 21750169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Eicosapentaenoic acid (EPA) efficacy for colorectal aberrant crypt foci (ACF): a double-blind randomized controlled trial.
    Higurashi T; Hosono K; Endo H; Takahashi H; Iida H; Uchiyama T; Ezuka A; Uchiyama S; Yamada E; Ohkubo H; Sakai E; Maeda S; Morita S; Natsumeda Y; Nagase H; Nakajima A
    BMC Cancer; 2012 Sep; 12():413. PubMed ID: 22992267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Occurrence of colorectal aberrant crypt foci depending on age and dietary patterns of patients.
    Kowalczyk M; Orłowski M; Siermontowski P; Mucha D; Zinkiewicz K; Kurpiewski W; Zieliński E; Kowalczyk I; Pedrycz A
    BMC Cancer; 2018 Feb; 18(1):213. PubMed ID: 29466973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Effect of Smoking on the Number and Type of Rectal Aberrant Crypt Foci (ACF)-First Identifiable Precursors of Colorectal Cancer (CRC).
    Kowalczyk M; Klepacki Ł; Zieliński E; Kurpiewski W; Zinkiewicz K; Dyśko Ł; Pesta W
    J Clin Med; 2020 Dec; 10(1):. PubMed ID: 33375262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized Phase II Trial of Polyphenon E versus Placebo in Patients at High Risk of Recurrent Colonic Neoplasia.
    Sinicrope FA; Viggiano TR; Buttar NS; Song LMWK; Schroeder KW; Kraichely RE; Larson MV; Sedlack RE; Kisiel JB; Gostout CJ; Kalaiger AM; Patai ÁV; Della'Zanna G; Umar A; Limburg PJ; Meyers JP; Foster NR; Yang CS; Sontag S
    Cancer Prev Res (Phila); 2021 May; 14(5):573-580. PubMed ID: 33648940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The efficacy of a leukotriene receptor antagonist in the treatment of human rectal aberrant crypt foci: a nonrandomized, open-label, controlled trial.
    Higurashi T; Arimoto J; Ashikari K; Takatsu T; Misawa N; Yoshihara T; Matsuura T; Fuyuki A; Ohkubo H; Nakajima A
    BMC Cancer; 2020 Aug; 20(1):770. PubMed ID: 32807113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metformin suppresses colorectal aberrant crypt foci in a short-term clinical trial.
    Hosono K; Endo H; Takahashi H; Sugiyama M; Sakai E; Uchiyama T; Suzuki K; Iida H; Sakamoto Y; Yoneda K; Koide T; Tokoro C; Abe Y; Inamori M; Nakagama H; Nakajima A
    Cancer Prev Res (Phila); 2010 Sep; 3(9):1077-83. PubMed ID: 20810669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rectal aberrant crypt foci identified using high-magnification-chromoscopic colonoscopy: biomarkers for flat and depressed neoplasia.
    Hurlstone DP; Karajeh M; Sanders DS; Drew SK; Cross SS
    Am J Gastroenterol; 2005 Jun; 100(6):1283-9. PubMed ID: 15929758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Number of aberrant crypt foci in the rectum is a useful surrogate marker of colorectal adenoma recurrence.
    Uchiyama T; Takahashi H; Endo H; Kato S; Sakai E; Hosono K; Yoneda M; Inamori M; Hippo Y; Nakagama H; Nakajima A
    Dig Endosc; 2012 Sep; 24(5):353-7. PubMed ID: 22925289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dysplastic Aberrant Crypt Foci: Biomarkers of Early Colorectal Neoplasia and Response to Preventive Intervention.
    Clapper ML; Chang WL; Cooper HS
    Cancer Prev Res (Phila); 2020 Mar; 13(3):229-240. PubMed ID: 32132117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized double-blind trial of sulindac and etodolac to eradicate aberrant crypt foci and to prevent sporadic colorectal polyps.
    Takayama T; Nagashima H; Maeda M; Nojiri S; Hirayama M; Nakano Y; Takahashi Y; Sato Y; Sekikawa H; Mori M; Sonoda T; Kimura T; Kato J; Niitsu Y
    Clin Cancer Res; 2011 Jun; 17(11):3803-11. PubMed ID: 21385928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aberrant crypt foci as predictors of colorectal neoplasia on repeat colonoscopy.
    Anderson JC; Swede H; Rustagi T; Protiva P; Pleau D; Brenner BM; Rajan TV; Heinen CD; Levine JB; Rosenberg DW
    Cancer Causes Control; 2012 Feb; 23(2):355-61. PubMed ID: 22187142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive value of rectal aberrant crypt foci for intraepithelial neoplasia in ulcerative colitis - a cross-sectional study.
    Freire P; Figueiredo P; Cardoso R; Manuel Donato M; Ferreira M; Mendes S; Silva MR; Cipriano MA; Ferreira AM; Vasconcelos H; Portela F; Sofia C
    Scand J Gastroenterol; 2014 Oct; 49(10):1219-29. PubMed ID: 25157637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methylation study of tumor suppressor genes in human aberrant crypt foci, colorectal carcinomas, and normal colon.
    Sarangi J; Das P; Ahmad A; Sulaiman M; Ghosh S; Gupta B; Panwar R; Pal S; Yadav R; Ahuja V; Sen S; Upadhyay AD; Dash NR; Sharma A; Gupta SD
    J Cancer Res Ther; 2024 Jan; 20(1):268-274. PubMed ID: 38554332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of expression of DNA mismatch repair proteins in aberrant crypt foci identified in vivo by magnifying colonoscopy in subjects with hereditary nonpolyposic and sporadic colon rectal cancer.
    Ramírez-Ramírez MA; Sobrino-Cossío S; de la Mora-Levy JG; Hernández-Guerrero A; Macedo-Reyes Vde J; Maldonado-Martínez HA; Alonso-Larraga JO; Ramírez-Solis ME
    J Gastrointest Cancer; 2012 Jun; 43(2):209-14. PubMed ID: 21744313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship of human rectal aberrant crypt foci and formation of colorectal polyp: One-year following up after polypectomy.
    Takahashi H; Yamada E; Ohkubo H; Sakai E; Higurashi T; Uchiyama T; Hosono K; Endo H; Nakajima A
    World J Gastrointest Endosc; 2012 Dec; 4(12):561-4. PubMed ID: 23293726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.